Premier Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-2,023
Closed -$1.46M 79
2022
Q4
$1.46M Sell
2,023
-1,038
-34% -$749K 1.83% 17
2022
Q3
$2.11M Sell
3,061
-880
-22% -$606K 2.19% 14
2022
Q2
$2.29M Sell
3,941
-6,235
-61% -$3.63M 1.85% 25
2022
Q1
$7.11M Sell
10,176
-5,463
-35% -$3.82M 2.21% 20
2021
Q4
$9.88M Sell
15,639
-5,425
-26% -$3.43M 1.72% 24
2021
Q3
$12.7M Buy
21,064
+1,184
+6% +$717K 1.77% 22
2021
Q2
$11.1M Buy
+19,880
New +$11.1M 1.64% 26
2020
Q2
Sell
-9,594
Closed -$4.69M 142
2020
Q1
$4.69M Buy
+9,594
New +$4.69M 1.96% 23
2019
Q2
Sell
-33,911
Closed -$13.9M 149
2019
Q1
$13.9M Buy
33,911
+404
+1% +$166K 3.31% 2
2018
Q4
$12.5M Buy
33,507
+267
+0.8% +$99.7K 3.36% 6
2018
Q3
$13.4M Sell
33,240
-630
-2% -$255K 3% 10
2018
Q2
$11.7M Buy
33,870
+4,005
+13% +$1.38M 2.75% 13
2018
Q1
$10.3M Sell
29,865
-1,011
-3% -$348K 2.3% 19
2017
Q4
$11.6M Sell
30,876
-1,681
-5% -$632K 2.59% 13
2017
Q3
$14.6M Sell
32,557
-840
-3% -$376K 3.26% 6
2017
Q2
$16.4M Sell
33,397
-1,055
-3% -$518K 3.79% 2
2017
Q1
$13.4M Buy
34,452
+113
+0.3% +$43.8K 3.17% 7
2016
Q4
$12.6M Sell
34,339
-501
-1% -$184K 3.27% 8
2016
Q3
$14M Sell
34,840
-1,735
-5% -$697K 3.48% 5
2016
Q2
$12.8M Sell
36,575
-145
-0.4% -$50.6K 3.3% 9
2016
Q1
$13.2M Buy
36,720
+240
+0.7% +$86.5K 3.41% 10
2015
Q4
$19.8M Sell
36,480
-415
-1% -$225K 4.93% 1
2015
Q3
$17.2M Sell
36,895
-310
-0.8% -$144K 4.34% 3
2015
Q2
$19M Sell
37,205
-80
-0.2% -$40.8K 4.47% 2
2015
Q1
$16.8M Sell
37,285
-680
-2% -$307K 3.9% 2
2014
Q4
$15.6M Sell
37,965
-45
-0.1% -$18.5K 3.81% 5
2014
Q3
$13.7M Sell
38,010
-5
-0% -$1.8K 3.51% 6
2014
Q2
$10.7M Buy
38,015
+10,935
+40% +$3.09M 2.72% 19
2014
Q1
$8.13M Buy
27,080
+360
+1% +$108K 2.25% 25
2013
Q4
$7.35M Buy
26,720
+455
+2% +$125K 1.96% 29
2013
Q3
$8.22M Buy
+26,265
New +$8.22M 2.37% 24